Related Experiment Video
Updated: Jan 24, 2026

Methods to Assess Beta Cell Death Mediated by Cytotoxic T Lymphocytes
Published on: June 16, 2011
Thalidezine triggers Cathepsin B-mediated cell death in T-cell lymphoma by disrupting lysosomal function
Yingjie Qing1, Su Xu2, Dawei Yang3
1State Key Laboratory of Technologies for Chinese Medicine Pharmaceutical Process Control and Intelligent Manufacture, Nanjing University of Chinese Medicine, Nanjing, China.
Abstract:
T-cell lymphoma (TCL) is an aggressive malignancy defined by poor prognosis and therapeutic resistance, demanding innovative strategies. Targeting the lysosome to induce cell death has emerged as a powerful anti-cancer strategy, however its potential as a therapeutic target in TCL is yet to be fully developed. Here we report that Thalidezine (Tha) is a new and highly selective lysosomotropic agent (LA) with strong activity against TCL. Thalidezine diminished the acidic pH, and more importantly, induced the lysosomal membrane permeabilization (LMP). This LMP was not a passive event; it triggered the immediate and critical release of the protease Cathepsin B (CTSB) from the lysosomal lumen. We demonstrate that this cytosolic CTSB is the key executioner, directly initiating the apoptotic cascade through caspase-3 activation. Remarkably, CTSB knockdown rescued TCL cells from Tha-induced death, confirming that the CTSB-caspase axis constitutes the major death axis. Furthermore, Tha demonstrated significant in vivo efficacy in TCL cells-bearing NOD/SCID mice. In conclusion our results reveal Tha is a novel potent drug candidate and uncover a defined mechanism by weaponizing lysosomes to release CTSB, thereby establishing a therapeutically relevant vulnerability in TCL.
Insights
Thalidezine, a novel lysosomotropic agent, effectively targets T-cell lymphoma (TCL) by inducing lysosomal membrane permeabilization. This releases Cathepsin B, initiating apoptosis and offering a promising therapeutic strategy for TCL.
Area of Science:
- Oncology
- Cell Biology
- Pharmacology
Background:
- T-cell lymphoma (TCL) is an aggressive cancer with poor prognosis and resistance to therapy.
- Targeting cellular lysosomes for cancer cell death is a developing strategy.
- The therapeutic potential of lysosomotropic agents in TCL requires further investigation.
Purpose of the Study:
- To evaluate Thalidezine (Tha) as a novel lysosomotropic agent (LA) against T-cell lymphoma (TCL).
- To elucidate the mechanism of cell death induced by Thalidezine in TCL.
- To assess the in vivo efficacy of Thalidezine in a mouse model of TCL.
Main Methods:
- Treatment of TCL cells with Thalidezine.
- Measurement of lysosomal pH and lysosomal membrane permeabilization (LMP).
- Assessment of Cathepsin B (CTSB) release and its role in apoptosis via caspase-3 activation.
- In vivo efficacy studies in NOD/SCID mice bearing TCL xenografts.
Main Results:
- Thalidezine selectively targeted TCL cells, reducing lysosomal pH and inducing LMP.
- LMP triggered the release of CTSB into the cytosol, activating caspase-3 and initiating apoptosis.
- CTSB knockdown significantly protected TCL cells from Thalidezine-induced death.
- Thalidezine demonstrated significant anti-tumor activity in vivo.
Conclusions:
- Thalidezine is a potent drug candidate for T-cell lymphoma treatment.
- The mechanism involves lysosome weaponization, releasing CTSB to trigger apoptosis.
- This highlights a therapeutically relevant vulnerability in TCL.
Related Concept Videos
Overview of Cell Death
Cell death was observed in the early 19th century, but there was no experimental evidence to prove it. In 1842, Carl Vogt first discovered cell death in a metamorphic toad; however, it was not termed ‘cell death.’ Scientists discovered different cell death pathways only in the...
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
Lysosomes
Lysosomal Hydrolases
Cell-mediated Immune Responses
T Cell Types and Functions
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

